Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 303

1.

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.

Pan Y, Robertson G, Pedersen L, Lim E, Hernandez-Herrera A, Rowat AC, Patil SL, Chan CK, Wen Y, Zhang X, Basu-Roy U, Mansukhani A, Chu A, Sipahimalani P, Bowlby R, Brooks D, Thiessen N, Coarfa C, Ma Y, Moore RA, Schein JE, Mungall AJ, Liu J, Pecot CV, Sood AK, Jones SJ, Marra MA, Gunaratne PH.

Oncotarget. 2017 Mar 7;8(10):17406. doi: 10.18632/oncotarget.15921. No abstract available.

2.

Spatial heterogeneity in medulloblastoma.

Morrissy AS, Cavalli FMG, Remke M, Ramaswamy V, Shih DJH, Holgado BL, Farooq H, Donovan LK, Garzia L, Agnihotri S, Kiehna EN, Mercier E, Mayoh C, Papillon-Cavanagh S, Nikbakht H, Gayden T, Torchia J, Picard D, Merino DM, Vladoiu M, Luu B, Wu X, Daniels C, Horswell S, Thompson YY, Hovestadt V, Northcott PA, Jones DTW, Peacock J, Wang X, Mack SC, Reimand J, Albrecht S, Fontebasso AM, Thiessen N, Li Y, Schein JE, Lee D, Carlsen R, Mayo M, Tse K, Tam A, Dhalla N, Ally A, Chuah E, Cheng Y, Plettner P, Li HI, Corbett RD, Wong T, Long W, Loukides J, Buczkowicz P, Hawkins CE, Tabori U, Rood BR, Myseros JS, Packer RJ, Korshunov A, Lichter P, Kool M, Pfister SM, Schüller U, Dirks P, Huang A, Bouffet E, Rutka JT, Bader GD, Swanton C, Ma Y, Moore RA, Mungall AJ, Majewski J, Jones SJM, Das S, Malkin D, Jabado N, Marra MA, Taylor MD.

Nat Genet. 2017 May;49(5):780-788. doi: 10.1038/ng.3838. Epub 2017 Apr 10.

PMID:
28394352
3.

Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban.

Coleman C, Yuan Z, Schein J, Crivera C, Ashton V, Laliberté F, Lefebvre P, Peterson ED.

Curr Med Res Opin. 2017 Jun;33(6):1033-1043. doi: 10.1080/03007995.2017.1297932. Epub 2017 Apr 2.

PMID:
28366075
4.

Integrated Molecular Characterization of Uterine Carcinosarcoma.

Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, Hu X, Ling S, Soslow RA, Broaddus RR, Zuna RE, Robertson G, Laird PW, Kucherlapati R, Mills GB; Cancer Genome Atlas Research Network., Weinstein JN, Zhang J, Akbani R, Levine DA.

Cancer Cell. 2017 Mar 13;31(3):411-423. doi: 10.1016/j.ccell.2017.02.010.

5.

Vacuum arc plasma deposition of thin titanium dioxide films on silicone elastomer as a functional coating for medical applications.

Boudot C, Kühn M, Kühn-Kauffeldt M, Schein J.

Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:508-514. doi: 10.1016/j.msec.2016.12.045. Epub 2016 Dec 12.

PMID:
28254325
6.

Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis.

Nguyen E, Coleman CI, Peacock WF, Wells PS, Weeda ER, Ashton V, Crivera C, Wildgoose P, Schein JR, Bunz TJ, Fermann GJ.

BMC Pulm Med. 2017 Feb 13;17(1):37. doi: 10.1186/s12890-017-0379-5.

7.

External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans.

Kohn CG, Weeda ER, Kumar N, Wells PS, Peacock WF, Fermann GJ, Wang L, Baser O, Schein JR, Crivera C, Coleman CI.

Intern Emerg Med. 2017 Feb 9. doi: 10.1007/s11739-017-1625-9. [Epub ahead of print]

PMID:
28185131
8.

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, Lichtenberg TM, Murray BA, Ghayee HK, Else T, Ling S, Jefferys SR, de Cubas AA, Wenz B, Korpershoek E, Amelio AL, Makowski L, Rathmell WK, Gimenez-Roqueplo AP, Giordano TJ, Asa SL, Tischler AS; Cancer Genome Atlas Research Network., Pacak K, Nathanson KL, Wilkerson MD.

Cancer Cell. 2017 Feb 13;31(2):181-193. doi: 10.1016/j.ccell.2017.01.001. Epub 2017 Feb 2.

PMID:
28162975
9.

Integrated genomic and molecular characterization of cervical cancer.

Cancer Genome Atlas Research Network.; Albert Einstein College of Medicine.; Analytical Biological Services.; Barretos Cancer Hospital.; Baylor College of Medicine.; Beckman Research Institute of City of Hope.; Buck Institute for Research on Aging.; Canada's Michael Smith Genome Sciences Centre.; Harvard Medical School.; Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services.; HudsonAlpha Institute for Biotechnology.; ILSbio, LLC.; Indiana University School of Medicine.; Institute of Human Virology.; Institute for Systems Biology.; International Genomics Consortium.; Leidos Biomedical.; Massachusetts General Hospital.; McDonnell Genome Institute at Washington University.; Medical College of Wisconsin.; Medical University of South Carolina.; Memorial Sloan Kettering Cancer Center.; Montefiore Medical Center.; NantOmics.; National Cancer Institute.; National Hospital, Abuja, Nigeria.; National Human Genome Research Institute.; National Institute of Environmental Health Sciences.; National Institute on Deafness &Other Communication Disorders.; Ontario Tumour Bank, London Health Sciences Centre.; Ontario Tumour Bank, Ontario Institute for Cancer Research.; Ontario Tumour Bank, The Ottawa Hospital.; Oregon Health &Science University.; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center.; SRA International.; St Joseph's Candler Health System.; Eli &Edythe L. Broad Institute of Massachusetts Institute of Technology &Harvard University.; Research Institute at Nationwide Children's Hospital.; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University.; University of Bergen.; University of Texas MD Anderson Cancer Center.; University of Abuja Teaching Hospital.; University of Alabama at Birmingham.; University of California, Irvine.; University of California Santa Cruz.; University of Kansas Medical Center.; University of Lausanne.; University of New Mexico Health Sciences Center.; University of North Carolina at Chapel Hill.; University of Oklahoma Health Sciences Center.; University of Pittsburgh.; University of São Paulo, Ribeir ão Preto Medical School.; University of Southern California.; University of Washington.; University of Wisconsin School of Medicine &Public Health.; Van Andel Research Institute.; Washington University in St Louis..

Nature. 2017 Mar 16;543(7645):378-384. doi: 10.1038/nature21386. Epub 2017 Jan 23.

PMID:
28112728
10.

Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status.

Weeda ER, Peacock WF, Fermann GJ, Baugh CW, Wells PS, Ashton V, Crivera C, Wildgoose P, Schein JR, Coleman CI.

Int J Clin Pract. 2017 Jan;71(1). doi: 10.1111/ijcp.12915.

PMID:
28097761
11.

Integrated genomic characterization of oesophageal carcinoma.

Cancer Genome Atlas Research Network.; Analysis Working Group: Asan University.; BC Cancer Agency.; Brigham and Women’s Hospital.; Broad Institute.; Brown University.; Case Western Reserve University.; Dana-Farber Cancer Institute.; Duke University.; Greater Poland Cancer Centre.; Harvard Medical School.; Institute for Systems Biology.; KU Leuven.; Mayo Clinic.; Memorial Sloan Kettering Cancer Center.; National Cancer Institute.; Nationwide Children’s Hospital.; Stanford University.; University of Alabama.; University of Michigan.; University of North Carolina.; University of Pittsburgh.; University of Rochester.; University of Southern California.; University of Texas MD Anderson Cancer Center.; University of Washington.; Van Andel Research Institute.; Vanderbilt University.; Washington University.; Genome Sequencing Center: Broad Institute.; Washington University in St. Louis.; Genome Characterization Centers: BC Cancer Agency.; Broad Institute.; Harvard Medical School.; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University.; University of North Carolina.; University of Southern California Epigenome Center.; University of Texas MD Anderson Cancer Center.; Van Andel Research Institute.; Genome Data Analysis Centers: Broad Institute.; Brown University:.; Harvard Medical School.; Institute for Systems Biology.; Memorial Sloan Kettering Cancer Center.; University of California Santa Cruz.; University of Texas MD Anderson Cancer Center.; Biospecimen Core Resource: International Genomics Consortium.; Research Institute at Nationwide Children’s Hospital.; Tissue Source Sites: Analytic Biologic Services.; Asan Medical Center.; Asterand Bioscience.; Barretos Cancer Hospital.; BioreclamationIVT.; Botkin Municipal Clinic.; Chonnam National University Medical School.; Christiana Care Health System.; Cureline.; Duke University.; Emory University.; Erasmus University.; Indiana University School of Medicine.; Institute of Oncology of Moldova.; International Genomics Consortium.; Invidumed.; Israelitisches Krankenhaus Hamburg.; Keimyung University School of Medicine.; Memorial Sloan Kettering Cancer Center.; National Cancer Center Goyang.; Ontario Tumour Bank.; Peter MacCallum Cancer Centre.; Pusan National University Medical School.; Ribeirão Preto Medical School.; St. Joseph’s Hospital &Medical Center.; St. Petersburg Academic University.; Tayside Tissue Bank.; University of Dundee.; University of Kansas Medical Center.; University of Michigan.; University of North Carolina at Chapel Hill.; University of Pittsburgh School of Medicine.; University of Texas MD Anderson Cancer Center.; Disease Working Group: Duke University.; Memorial Sloan Kettering Cancer Center.; National Cancer Institute.; University of Texas MD Anderson Cancer Center.; Yonsei University College of Medicine.; Data Coordination Center: CSRA Inc.; Project Team: National Institutes of Health..

Nature. 2017 Jan 12;541(7636):169-175. doi: 10.1038/nature20805. Epub 2017 Jan 4.

PMID:
28052061
12.

Endothelialization and characterization of titanium dioxide-coated gas-exchange membranes for application in the bioartificial lung.

Pflaum M, Kühn-Kauffeldt M, Schmeckebier S, Dipresa D, Chauhan K, Wiegmann B, Haug RJ, Schein J, Haverich A, Korossis S.

Acta Biomater. 2017 Mar 1;50:510-521. doi: 10.1016/j.actbio.2016.12.017. Epub 2016 Dec 9.

PMID:
27956361
13.

First diagnosis of septic arthritis in a dinosaur.

Anné J, Hedrick BP, Schein JP.

R Soc Open Sci. 2016 Aug 3;3(8):160222. eCollection 2016 Aug.

14.

Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions.

Margolis JM, Deitelzweig S, Kline J, Tran O, Smith DM, Bookhart B, Crivera C, Schein J.

J Am Heart Assoc. 2016 Oct 6;5(10). pii: e003788.

15.

Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation.

McHorney CA, Peterson ED, Laliberté F, Germain G, Nelson WW, Crivera C, Schein J, Lefebvre P.

Clin Ther. 2016 Nov;38(11):2477-2488. doi: 10.1016/j.clinthera.2016.09.014. Epub 2016 Oct 24.

PMID:
27789043
16.

Patterns of international normalized ratio values among new warfarin patients with nonvalvular atrial fibrillation.

Nelson WW, Milentijevic D, Wang L, Baser O, Damaraju CV, Schein JR.

Blood Coagul Fibrinolysis. 2016 Dec;27(8):899-906.

PMID:
26886362
17.

External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications.

Coleman CI, Peacock WF, Fermann GJ, Crivera C, Weeda ER, Hull M, DuCharme M, Becker L, Schein JR.

BMC Health Serv Res. 2016 Oct 22;16(1):610.

18.

Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin.

Weeda ER, Wells PS, Peacock WF, Fermann GJ, Baugh CW, Ashton V, Crivera C, Wildgoose P, Schein JR, Coleman CI.

Intern Emerg Med. 2017 Apr;12(3):311-318. doi: 10.1007/s11739-016-1552-1. Epub 2016 Oct 18.

PMID:
27757790
19.

Pulmonary Embolism Inpatients Treated With Rivaroxaban Had Shorter Hospital Stays and Lower Costs Compared With Warfarin.

Margolis JM, Deitelzweig S, Kline J, Tran O, Smith DM, Crivera C, Bookhart B, Schein J.

Clin Ther. 2016 Nov;38(11):2496-2503. doi: 10.1016/j.clinthera.2016.09.007. Epub 2016 Oct 15.

20.

Impact of CHA2DS2VASc Score on Candidacy for Anticoagulation in Patients With Atrial Fibrillation: A Multi-payer Analysis.

Patel AA, Nelson WW, Schein J.

Clin Ther. 2016 Oct;38(10):2196-2203.e5. doi: 10.1016/j.clinthera.2016.08.011. Epub 2016 Sep 23.

PMID:
27671867

Supplemental Content

Loading ...
Support Center